Fitness cost: A bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1325-1332

  Nielsen, Karen L ^a,b   Pedersen, Thomas M ^a   Udekwu, Klas I ^c   Petersen, Andreas ^a   Skov, Robert L ^a   Hansen, Lars H ^d   Hughes, Diarmaid ^e   Frimodt Møller, Niels ^a,b  

^a STATENS SERUM INSTITUT   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antimicrobial resistance; Bacteraemia; Competition; Mathematical modelling; Regression analysis; Spa type

Indexed keywords

BACTERIAL PROTEIN; PENICILLIN BINDING PROTEIN 2A; PROTEIN TETK; PROTEIN TETM; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL FITNESS; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIOPHAGE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DENMARK; DRUG USE; EPIDEMIC; GENOTYPE; INFECTION CONTROL; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PHENOTYPE;

BACTERIOPHAGE TYPING; DENMARK; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENERGY METABOLISM; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MODELS, THEORETICAL; STAPHYLOCOCCAL INFECTIONS;

EID: 84861116792     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks051     Document Type: Article

References (32)

1. Ayliffe GAJ, Lilly HA, Lowbury EJL. Decline of the hospital Staphylococcus? Incidence of multiresistant Staph. aureus in three Birmingham hospitals. Lancet 1979; i: 538-41.
2. DANMAP 2007-Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Foods and Humans in Denmark. http://www.danmap.org/Downloads/~/media/Projekt%20sites/Danmap/DANMAP%20reports/Danmap_2007.ashx (22 January 2012, date last accessed).
3. DANMAP 98-Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Food and humans in Denmark. http://www.danmap.org/Downloads/~/media/Projekt%20sites/Danmap/DANMAP%20reports/Danmap_1998.ashx (22 January 2012, date last accessed).
4. Westh H, Jarlov JO, Kjersem H et al. The disappearance of multiresistant Staphylococcus aureus in Denmark: changes in strains of the 83A complex between 1969 and 1989. Clin Infect Dis 1992; 14: 1186-94.
5. Rosdahl VT, Knudsen AM. The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991; 12: 83-8.
6. Rosendal K, Jessen O, Bentzon MW et al. Antibiotic policy and spread of Staphylococcus aureus strains in Danish hospitals, 1969-1974. Acta Pathol Microbiol Scand B 1977; 85: 143-52.
7. Ender M, McCallum N, Adhikari R et al. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48: 2295-7.
8. Andersson D, Hughes D. Effects of antibiotic resistance on bacterial fitness, virulence, and transmission. In: Baquero F, Nombela C, Cassell G et al., eds. Evolutionary Biology of Bacterial and Fungal Pathogens. Washington, DC: ASM Press, 2007; 307-8.
9. Lindgren PK, Marcusson LL, Sandvang D et al. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 2005; 49: 2343-51.
10. Nagaev I, Bjorkman J, Andersson DI et al. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol 2001; 40: 433-9.
11. Larsen AR, Stegger M, Sorum M. spa typing directly from a mecA, spa and pvl multiplex PCR assay-a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance. Clin Microbiol Infect 2008; 14: 611-4.
12. Rosco Diagnostica. Neo-Sensitabs Testing. Taastrup: Rosco Diagnostica, 2005.
13. Strommenger B, Kettlitz C, Werner G et al. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol 2003; 41: 4089-94.
14. Hauschild T, Vukovic D, Dakic I et al. Aminoglycoside resistance in members of the Staphylococcus sciuri group. Microb Drug Resist 2007; 13: 77-84.
15. Kondo Y, Ito T, Ma XX et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother 2007; 51: 264-74.
16. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 2155-61.
17. Sander P, Springer B, Prammananan T et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother 2002; 46: 1204-11.
18. Austin DJ, Kakehashi M, Anderson RM. The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc Biol Sci 1997; 264: 1629-38.
19. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
20. Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc Biol Sci 1997; 264: 1287-91.
21. Monnet DL, Frimodt-Moller N. Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001; 7: 161-3.
22. Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10: 1432-41.
23. Jarlier V, Trystram D, Brun-Buisson C et al. Curbing methicillinresistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010; 170: 552-9.
24. Parker MT, Hewitt JH. Methicillin resistance in Staphylococcus aureus. Lancet 1970; 295: 800-4.
25. Rountree PM, Vickery AM. Further observations on methicillin-resistant staphylococci. Med J Aust 1973; 1: 1030-4.
26. Williams RE, Dean BA. Phage types of Staphylococcus aureus in one hospital 1961-72. J Hyg (Lond) 1974; 73: 375-82.
27. Leclercq R. Methicillin-resistant Staphylococcus aureus in France: evolution and present status. In: Brun Buisson C, Casewell MW, El Sohl N et al., eds. Maurice Rapin Colloquia: Methicillin-Resistant Staphylococci. Paris: Flammarion, 1995; 92-9.
28. Richet H, Wiesel M, Le Gallou F et al. Methicillin-resistant Staphylococcus aureus control in hospitals: the French experience. Infect Control Hosp Epidemiol 1996; 17: 509-11.
29. Vickery AM, Beardpegler MA, Stubbs E. Phage-typing patterns and lysogenicity of methicillin-resistant strains of Staphylococcus aureus from Sydney, Australia, 1965-85. J Med Microbiol 1986; 22: 209-16.
30. Parker MT, Asheshov EH, Hewitt JH et al. Endemic staphylococcal infections in hospitals. Ann N Y Acad Sci 1974; 236: 466-84.
31. Sundqvist M, Geli P, Andersson DI et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2010; 65: 350-60.
32. Nilsson AI, Berg OG, Aspevall O et al. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 2003; 47: 2850-8.